Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
2
×
biotech
clinical trials
fda
life sciences
national
2
×
national blog main
san francisco blog main
san francisco top stories
abaloparatide
alder biopharmaceuticals
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
chronic migraine
david rind
detroit blog main
detroit top stories
eli lilly
episodic migraine
eptinezumab
erenumab
europe blog main
europe top stories
european commission
food and drug administration
fremanezumab
galcanezumab
indiana blog main
indiana top stories
institute for clinical and economic review
migraine research foundation
migraines
national top stories
new york blog main
new york top stories
novartis
osteoporosis
What
amgen
2
×
approval
developed
drug
nod
amgen’s
candidates
carries
class
europe
european
fda
gets
head
heart
marketing
medicine
medicines
migraine
new
osteoporosis
pain
preventive
raise
risk
starts
warning
wins
won
Language
unset
Current search:
amgen
×
national
×
amgen
×
@xconomy.com
4 years ago
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines